Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & Administrative
Others
Shares Issued
Ratios

SELLAS Life Sciences (SLS) Shares Outstanding (2019 - 2024)

SELLAS Life Sciences (SLS) has disclosed Shares Outstanding for 9 consecutive years, with $64.4 million as the latest value for Q3 2024.

  • Quarterly Shares Outstanding rose 126.75% to $64.4 million in Q3 2024 from the year-ago period, while the trailing twelve-month figure was $64.4 million through Sep 2024, up 126.75% year-over-year, with the annual reading at $32.1 million for FY2023, 52.97% up from the prior year.
  • Shares Outstanding for Q3 2024 was $64.4 million at SELLAS Life Sciences, up from $57.8 million in the prior quarter.
  • The five-year high for Shares Outstanding was $64.4 million in Q3 2024, with the low at $6.7 million in Q1 2020.
  • Average Shares Outstanding over 5 years is $24.9 million, with a median of $20.6 million recorded in 2022.
  • The sharpest move saw Shares Outstanding skyrocketed 235.44% in 2020, then rose 5.44% in 2022.
  • Over 5 years, Shares Outstanding stood at $14.3 million in 2020, then rose by 11.51% to $15.9 million in 2021, then surged by 32.15% to $21.0 million in 2022, then soared by 52.97% to $32.1 million in 2023, then soared by 100.36% to $64.4 million in 2024.
  • According to Business Quant data, Shares Outstanding over the past three periods came in at $64.4 million, $57.8 million, and $56.3 million for Q3 2024, Q2 2024, and Q1 2024 respectively.